vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and iQSTEL Inc (IQST). Click either name above to swap in a different company.

CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $84.2M, roughly 1.6× iQSTEL Inc). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs -3.2%, a 85.7% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs -14.9%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 28.0%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.

CTRE vs IQST — Head-to-Head

Bigger by revenue
CTRE
CTRE
1.6× larger
CTRE
$134.9M
$84.2M
IQST
Growing faster (revenue YoY)
CTRE
CTRE
+70.0% gap
CTRE
55.1%
-14.9%
IQST
Higher net margin
CTRE
CTRE
85.7% more per $
CTRE
82.5%
-3.2%
IQST
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
28.0%
IQST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
IQST
IQST
Revenue
$134.9M
$84.2M
Net Profit
$111.3M
$-2.7M
Gross Margin
3.5%
Operating Margin
-2.9%
Net Margin
82.5%
-3.2%
Revenue YoY
55.1%
-14.9%
Net Profit YoY
113.5%
-44.5%
EPS (diluted)
$0.52
$-0.92

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
IQST
IQST
Q4 25
$134.9M
$84.2M
Q3 25
$132.4M
$102.9M
Q2 25
$112.5M
$72.2M
Q1 25
$96.6M
$57.6M
Q4 24
$86.9M
$98.9M
Q3 24
$77.4M
$54.2M
Q2 24
$68.9M
$78.6M
Q1 24
$63.1M
$51.4M
Net Profit
CTRE
CTRE
IQST
IQST
Q4 25
$111.3M
$-2.7M
Q3 25
$74.9M
$-2.3M
Q2 25
$68.5M
$-2.3M
Q1 25
$65.8M
$-1.1M
Q4 24
$52.1M
$-1.9M
Q3 24
$33.4M
$-773.0K
Q2 24
$10.8M
$-2.0M
Q1 24
$28.7M
$-580.2K
Gross Margin
CTRE
CTRE
IQST
IQST
Q4 25
3.5%
Q3 25
2.7%
Q2 25
2.6%
Q1 25
3.4%
Q4 24
2.7%
Q3 24
3.7%
Q2 24
2.8%
Q1 24
2.7%
Operating Margin
CTRE
CTRE
IQST
IQST
Q4 25
-2.9%
Q3 25
58.1%
-0.5%
Q2 25
61.3%
-0.9%
Q1 25
-1.0%
Q4 24
-0.3%
Q3 24
43.0%
-0.1%
Q2 24
15.1%
-0.4%
Q1 24
-0.4%
Net Margin
CTRE
CTRE
IQST
IQST
Q4 25
82.5%
-3.2%
Q3 25
56.6%
-2.3%
Q2 25
60.9%
-3.3%
Q1 25
68.1%
-2.0%
Q4 24
60.0%
-1.9%
Q3 24
43.2%
-1.4%
Q2 24
15.6%
-2.5%
Q1 24
45.6%
-1.1%
EPS (diluted)
CTRE
CTRE
IQST
IQST
Q4 25
$0.52
$-0.92
Q3 25
$0.35
$-0.68
Q2 25
$0.35
$-0.82
Q1 25
$0.35
$-0.44
Q4 24
$0.30
$-1.19
Q3 24
$0.21
$-0.40
Q2 24
$0.07
$-0.90
Q1 24
$0.22
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
IQST
IQST
Cash + ST InvestmentsLiquidity on hand
$198.0M
$2.2M
Total DebtLower is stronger
$894.2M
$4.1M
Stockholders' EquityBook value
$4.0B
$16.3M
Total Assets
$5.1B
$51.1M
Debt / EquityLower = less leverage
0.22×
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
IQST
IQST
Q4 25
$198.0M
$2.2M
Q3 25
$712.5M
$2.3M
Q2 25
$306.1M
$2.0M
Q1 25
$26.5M
$1.1M
Q4 24
$213.8M
$2.5M
Q3 24
$377.1M
$2.1M
Q2 24
$495.1M
$797.2K
Q1 24
$451.2M
$2.7M
Total Debt
CTRE
CTRE
IQST
IQST
Q4 25
$894.2M
$4.1M
Q3 25
$893.8M
$2.7M
Q2 25
$1.2B
$4.5M
Q1 25
$822.1M
$3.5M
Q4 24
$396.9M
$2.5M
Q3 24
$396.7M
$3.2M
Q2 24
$671.1M
$2.5M
Q1 24
$595.9M
$194.0K
Stockholders' Equity
CTRE
CTRE
IQST
IQST
Q4 25
$4.0B
$16.3M
Q3 25
$4.0B
$17.9M
Q2 25
$3.3B
$14.3M
Q1 25
$2.9B
$11.6M
Q4 24
$2.9B
$11.9M
Q3 24
$2.4B
$8.1M
Q2 24
$1.9B
$7.6M
Q1 24
$1.7B
$8.4M
Total Assets
CTRE
CTRE
IQST
IQST
Q4 25
$5.1B
$51.1M
Q3 25
$5.1B
$46.9M
Q2 25
$4.7B
$51.4M
Q1 25
$3.9B
$42.0M
Q4 24
$3.4B
$79.0M
Q3 24
$2.9B
$32.4M
Q2 24
$2.7B
$30.0M
Q1 24
$2.3B
$22.1M
Debt / Equity
CTRE
CTRE
IQST
IQST
Q4 25
0.22×
0.25×
Q3 25
0.22×
0.15×
Q2 25
0.35×
0.31×
Q1 25
0.28×
0.31×
Q4 24
0.14×
0.21×
Q3 24
0.16×
0.40×
Q2 24
0.35×
0.34×
Q1 24
0.36×
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
IQST
IQST
Operating Cash FlowLast quarter
$394.0M
$-1.2M
Free Cash FlowOCF − Capex
$-1.2M
FCF MarginFCF / Revenue
-1.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters
$-4.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
IQST
IQST
Q4 25
$394.0M
$-1.2M
Q3 25
$100.9M
$-953.0K
Q2 25
$100.8M
$257.7K
Q1 25
$71.4M
$-1.9M
Q4 24
$244.3M
$-403.7K
Q3 24
$67.2M
$625.0K
Q2 24
$53.0M
$-2.6M
Q1 24
$48.8M
$-536.9K
Free Cash Flow
CTRE
CTRE
IQST
IQST
Q4 25
$-1.2M
Q3 25
$-969.2K
Q2 25
$211.7K
Q1 25
$-2.0M
Q4 24
$-421.3K
Q3 24
$594.5K
Q2 24
$-2.6M
Q1 24
$-608.5K
FCF Margin
CTRE
CTRE
IQST
IQST
Q4 25
-1.5%
Q3 25
-0.9%
Q2 25
0.3%
Q1 25
-3.4%
Q4 24
-0.4%
Q3 24
1.1%
Q2 24
-3.4%
Q1 24
-1.2%
Capex Intensity
CTRE
CTRE
IQST
IQST
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.1%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
CTRE
CTRE
IQST
IQST
Q4 25
3.54×
Q3 25
1.35×
Q2 25
1.47×
Q1 25
1.08×
Q4 24
4.68×
Q3 24
2.01×
Q2 24
4.92×
Q1 24
1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

IQST
IQST

USA$53.2M63%
Other$29.9M35%
Switzerland$1.1M1%

Related Comparisons